Skip to content
Screener

Kodiak Sciences Inc KOD Restricted Cash

Restricted Cash at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$10.2M-48.5%
EyePoint, Inc. logo
EyePoint, Inc.EYPT
$150K0.0%
KLR
Kalaris TherapeuticsKLRS
$500K0.0%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$1.41M+187%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$1.61M0.0%
Glaukos logo
GlaukosGKOS
$3.12M-18.8%

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.72B+541%
Enterprise value$2.6B+576%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.

The source filing: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211951
Line itemMarch 31,2026December 31,2025
Cash and cash equivalents$169,530$209,862
Prepaid expenses and other current assets5,7284,954
Total current assets175,258214,816
Restricted cash6,1846,184
Property and equipment, net81,51285,258
Operating lease right-of-use asset34,37536,606
Other assets8,6778,669
Total assets$306,006$351,533

Item 1. Financial Statements (Unaudited).

FAQ

What is Kodiak Sciences Inc's restricted cash?
Kodiak Sciences Inc (KOD) reported restricted cash of $6.18M in Q1 2026.
How has Kodiak Sciences Inc's restricted cash changed year-over-year?
Kodiak Sciences Inc's restricted cash decreased by 0.0% year-over-year, from $6.18M to $6.18M.
What is the long-term trend for Kodiak Sciences Inc's restricted cash?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's restricted cash has grown at a -0.4% compound annual growth rate (CAGR), from $6.32M to $6.18M.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Ask your AI about Kodiak Sciences Inc's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude